See other companies on Welcome to the Jungle
NanoMosaic
Protein interrogation powered by nanoneedles
- 21-100 employees
- Healthcare
- B2B
- Biology
- MedTech
- West End, Waltham, MA
Jump to section
Company mission
NanoMosaic's mission is to genomicize proteomics.
Our take
Pioneering a new path in biotechnology, NanoMosaic is a medtech company that creates nanoneedles for biological and medical research. The MosaicNeedle is supported by the software platform Tessie. Together they help to create highly accurate and single molecule-sensitive samples for researchers.
The company has enjoyed considerable funding from biotech investors and launched its Tessie platform in 2022. Having exported its technology to leading hospitals and research institutes, NanoMosaic’s continued success indicates a thriving biotech sector that still has plenty of innovation opportunities.
Steph
Company Specialist at Welcome to the Jungle
Funding (1 round)
Dec 2021
$40.8m
SERIES A
Total funding: $40.8m
This company has top investors
Leadership
Qimin Quan
(CSO)Previously a Principal Investigator and Junior Fellow at the Rowland Institute at Harvard University.
John Boyce
(President & CEO)Co-founder of several companies, including TigerGene (current Managing Director), BrickBio (current President & CEO), and EnCapsid Therapeutics (current President & CEO). Former Fellow at Harvard University.